NGS and Germline Testing in Pancreatic Cancer

Opinion
Video

Panelists discuss how next-generation sequencing (NGS) and germline testing are increasingly being used in pancreatic cancer to identify genetic mutations, guide personalized treatment decisions, and inform the use of targeted therapies, ultimately improving patient outcomes and advancing precision medicine.

Recent Videos
2 experts are featured in this series.
5 experts in this video
2 experts are featured in this series.
4 experts in this video
4 experts in this video
Related Content